関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
ナノリットル滴を用いた個々の細胞の高度に並列した全ゲノム表現プロファイリング
Evan Z Macosko1, Anindita Basu2, Rahul Satija3
1Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Cell
|May 23, 2015
まとめ
Drop-seqは,細胞を滴状に封じ込み,そのRNAをユニークなバーコードでタグ付けすることで,単細胞ゲノミクスを迅速に可能にします. この方法では,マウスの44,808個の網膜細胞をプロファイリングし,39個の異なる細胞集団を明らかにし,遺伝子発現アトラスを作成しました.
科学分野:
- ゲノミクスゲノミクスとは
- 細胞生物学 細胞生物学
- バイオインフォマティックス
背景:
- 細胞は,多様な種類と状態を持つ基本的な生物学的単位です.
- 単細胞ゲノミクスは,細胞のアイデンティティと機能についての洞察を提供します.
- 現在の方法は,使いやすさとスケーラビリティの限界に直面しています.
研究 の 目的:
- 単細胞RNAプロファイルのスケーラブルで効率的な方法であるDrop-seqを導入する.
- コンプリートな細胞アトラスを作成する際にDrop-seqの応用を実証する.
主な方法:
- Drop-seqは,ナノリットルサイズの滴を使って個々の細胞をカプセル化します.
- ユニークなバーコードは,各細胞のRNA分子と関連付けられています.
- 何千もの細胞からのバーコードRNAの同時配列化.
主要な成果:
- マウスの44,808個の網膜細胞をプロフィール化しました.
- 39の転写的に異なる細胞集団を特定しました.
- 新しいサブタイプを含む網膜の遺伝子発現の分子アトラスを生成しました.
結論:
- Drop-seqは,単細胞の転写プロファイルの容易さと規模を大幅に向上させます.
- この技術は,単細胞のルーチン分析を可能にすることで,生物学的発見を加速します.
- 開発された網膜細胞アトラスは,神経科学の研究に貴重なリソースを提供します.
関連する概念動画
01:27Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
01:29Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
01:29Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
01:27Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K